Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T(3-4a)N0M0 Gastric Cancer Patients after D2 Gastrectomy

Aim. To investigate whether tumor size is a reasonable indication for adjuvant chemotherapy for T(3-4a)N0M0 gastric cancer patients after D2 gastrectomy. Method. We performed a retrospective study of 269 patients with a histological diagnosis of T(3-4a)N0M0 stage gastric cancer who underwent D2 radi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gastroenterol Res Pract
Autors principals: Chen, Shi, Ou-Yang, Li-Ying, Nie, Run-Cong, Li, Yuan-Fang, Xiang, Jun, Zhou, Zhi-Wei, Chen, Ying-Bo, Peng, Jun-Sheng
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346364/
https://ncbi.nlm.nih.gov/pubmed/28331491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4928736
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars